Australian Healthtech Stock News

It is hard to get excited after looking at Technology One's (ASX:TNE) recent performance, when its stock has declined...

The Australian market has shown a steady rise, gaining 7.2% over the past year with earnings projected to grow by 11% annually. In such conditions, identifying stocks with solid financials can be key to finding opportunities for growth and value. While the term "penny stock" may seem outdated, these smaller or newer companies can still offer significant potential when they are financially robust, presenting investors with unique opportunities for discovering quality investments.

If you have been watching Sunrise Energy Metals (ASX:SRL), now might be a moment worth a closer look. The company just announced it has received a letter of interest from the Export-Import Bank of the United States, potentially securing up to US$67 million in project financing for its Syerston Scandium Project. In addition, Sunrise completed the conversion of unlisted options, which resulted in the issuance of five million new shares and reinforced its balance sheet. Both moves could shape...

When a company asks for its shares to be placed in a trading halt, investors tend to take notice. That is exactly the spot PYC Therapeutics (ASX:PYC) finds itself in after a one-two punch: the abrupt exit of long-serving CEO Dr Rohan Hockings and the naming of Chairman Alan Tribe as interim Managing Director. The official word is that the halt is tied entirely to these board and management changes, with no new capital raise in the mix. In times like these, it is natural for shareholders to...

SKS Technologies Group Limited recently reported significant financial growth for the fiscal year ending June 2025, including a very large 92% increase in revenue and a 111.8% rise in net profit, alongside the declaration of a fully franked dividend of 6.0 cents per share. This marks a substantial increase in shareholder returns compared to the previous year's 1.0 cent dividend and highlights the impact of robust demand in digital infrastructure and smart technology solutions. We'll look at...

Earlier this week, Race Oncology announced a scientific discovery regarding the composition of the chemotherapy drug Bisantrene and has filed three patent applications based on these findings. This move highlights the company’s continued research efforts to strengthen its intellectual property protection in the oncology treatment space. We’ll explore how Race Oncology’s patent applications on new Bisantrene discoveries may influence its investment narrative and future opportunities. Find...

For many, the main point of investing is to generate higher returns than the overall market. But in any portfolio...

Key Insights Significant control over Medallion Metals by retail investors implies that the general public has more...

Insiders who bought Santa Fe Minerals Limited ( ASX:SFM ) stock in the last 12 months were richly rewarded last week...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

Insiders who bought AU$7.06m worth of HMC Capital Limited's ( ASX:HMC ) stock at an average buy price of AU$4.55 over...

Tabcorp Holdings Limited ( ASX:TAH ) shareholders have had their patience rewarded with a 36% share price jump in the...

Many Telix Pharmaceuticals Limited ( ASX:TLX ) insiders ditched their stock over the past year, which may be of...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Radiopharm Theranostics ( ASX:RAD ) Full Year 2025 Results Key Financial Results Net loss: AU$38.3m (loss narrowed by...

For many, the main point of investing is to generate higher returns than the overall market. But the main game is to...

Emmerson Resources ( ASX:ERM ) Full Year 2025 Results Key Financial Results Net loss: AU$2.42m (loss narrowed by 18...

Key Insights Clarity Pharmaceuticals' significant individual investors ownership suggests that the key decisions are...

Despite an already strong run, Emeco Holdings Limited ( ASX:EHL ) shares have been powering on, with a gain of 25% in...

Despite an already strong run, Bisalloy Steel Group Limited ( ASX:BIS ) shares have been powering on, with a gain of...

Key Insights Significant control over PRL Global by individual investors implies that the general public has more power...

Ideally, your overall portfolio should beat the market average. But in any portfolio, there will be mixed results...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...